Questionnaire based study of drugs taken by healthcare workers to prevent COVID 19
Not Applicable
Completed
- Registration Number
- CTRI/2020/05/025183
- Lead Sponsor
- Indian Council of Medical Research ICMR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 12089
Inclusion Criteria
All consenting Health Care Workers working in ICMR RUMC and collaborating hospitals caring
for Covid-19 patients
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method In HCW working in hospitals caring for COVID 19 patients, we will understand the rates of and types of drugs used, doses taken for prophylaxis, concomitant illness, concomitant medications, adverse reactions if any and the COVID-19 status at the end of the prophylaxis period. We will also understand the reasons why HCW did not take prophylaxis or discontinued.Timepoint: To be studied at the end of 12 weeks of prophylaxis or later if the recommendations change
- Secondary Outcome Measures
Name Time Method We will estimate /compare the Covid-19 status (SARS Co v2 positivity, symptoms) in those taking prophylactic treatment and those not taking prophylactic treatment.Timepoint: To be studied at the end of 12 weeks of prophylaxis or later if the recommendations change